Jatoi, Aminah

Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies

Dodson, S., Baracos, V. E., Jatoi, A., Evans, W. J., Cella, D., Dalton, J. T., & Steiner, M. S. (2011) · Annual Review of Medicine

Nutrition and Health in AgingMuscle Physiology and Disorders

Cited by 319

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly

Schild, S. E., Stella, P. J., Geyer, S. M., Bonner, J. A., McGinnis, W. L., Mailliard, J. A., Brindle, J., Jatoi, A., & Jett, J. R. (2003) · Journal of Clinical Oncology

Lung Cancer Diagnosis and TreatmentLung Cancer Research Studies

Cited by 222

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

Hofheinz, R.-D., Deplanque, G., Komatsu, Y., Kobayashi, Y., Ocvirk, J., Racca, P., Guenther, S., Zhang, J., Lacouture, M. E., & Jatoi, A. (2016) · The Oncologist

Chemotherapy-related skin toxicityHER2/EGFR in Cancer Research

Cited by 88

Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss

Lerner, L., Gyuris, J., Nicoletti, R., Gifford, J., Krieger, B., & Jatoi, A. (2016) · Oncology Letters

GDF15 and Related BiomarkersNutrition and Health in Aging

Cited by 55

The Wasting-Associated Metabolite Succinate Disrupts Myogenesis and Impairs Skeletal Muscle Regeneration

Arneson‐Wissink, P. C., Hogan, K. A., Ducharme, A. M., Samani, A., Jatoi, A., & Doles, J. D. (2020) · JCSM Rapid Communications

Muscle Physiology and DisordersNutrition and Health in Aging

Cited by 21

Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review

Smith, C. J., Almodallal, Y., & Jatoi, A. (2021) · Current Oncology Reports

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 11